OSE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
After market 10:44:28 pm | |||
| 7.41 EUR | -1.72% |
|
7.415 | +0.07% |
| 17/04 | OSE: licensing agreement with AbbVie enters into force | CF |
| 17/04 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 177M | - | |||||
| 50.85B | - | |||||
| 42.82B | ||||||
| 42.03B | ||||||
| 29.55B | ||||||
| 26.11B |
